SCHEMBL560291

SCHEMBL560291

Oc1c(Cl)cccc1Cc1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.58
▸ MEN1 O00255 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ HIF1A Q16665 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ BCL2 P10415 1/20 0.50
▸ BCL2L1 Q07817 1/20 0.50
▸ ALOX5 P09917 1/20 0.44
▸ ELANE P08246 2/20 0.44
▸ EGFR P00533 1/20 0.43
▸ ERBB2 P04626 1/20 0.43
▸ CTSG P08311 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Phenylphenol SCHEMBL8206003 0.86 HPGD (0.50) HSP90AA1MEN1CYP3A4HPGDALOX15
SCHEMBL9751984 0.85 HSP90AA1 (0.74) HSP90AA1EGFRERBB2
SCHEMBL4966037 0.85 BCL2 (0.60) BCL2BCL2L1ALOX5ELANECTSG
SCHEMBL4423210 0.81 SIGMAR1 (0.53) MEN1CYP3A4HPGDALOX15KMT2A
SCHEMBL10470450 0.80 HSPA5 (0.64) HSP90AA1MEN1CYP3A4HPGDALOX15
SCHEMBL2944708 0.79 BCL2 (0.59) MEN1CYP3A4HPGDALOX15KMT2A
SCHEMBL3301733 0.79 PNMT (0.56) MEN1CYP3A4HPGDALOX15KMT2A
SCHEMBL29091169 0.78 BCL2 (0.57) MEN1CYP3A4HPGDALOX15KMT2A
SCHEMBL3725692 0.78 ALDH1A1 (0.52) CYP3A4BCL2BCL2L1ALOX5
SCHEMBL30171004 0.78 ALDH1A1 (0.52) CYP3A4BCL2BCL2L1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2178967-A1 POLYOFIN COMPOSITIONS COMPRISING BIO-BASED STARCH MATERIALS Cereplast, Inc. (US) 2010-04-28 — — EP claimed
US-20090105791-A1 LIGHT EMITTING MEDICAL GARMENT DEVICE, KIT AND METHOD OF USING NEUROPHYSIOLOGICAL CONCEPTS LLC 2009-04-23 — — US claimed
WO-2009022195-A1 POLYOFIN COMPOSITIONS COMPRISING BIO-BASED STARCH MATERIALS CEREPLAST, INC. (DE) 2009-02-19 — — WO claimed
US-20090048368-A1 POLYOLEFIN COMPOSITIONS COMPRISING BIO-BASED STARCH MATERIALS CEREPLAST, INC. 2009-02-19 — — US claimed
EP-1190622-B1 Mixtures of phenolic and inorganic materials with antimicrobial activity CIBA SC HOLDING AG (CH) 2006-06-07 — — EP claimed
US-20050131100-A1 Mixtures of phenolic and inorganic materials with antimicrobial activity CIBA CORPORATION 2005-06-16 — — US claimed
EP-1537201-A1 HARD SURFACE TREATING COMPOSITIONS Reckitt Benckiser Inc. (US) 2005-06-08 — — EP claimed
WO-2004024861-A1 HARD SURFACE TREATING COMPOSITIONS RECKITT BENCKISER INC (US) 2004-03-25 — — WO claimed
US-20030125413-A1 Mixtures of phenolic and inorganic materials with antimicrobial activity CIBA CORPORATION 2003-07-03 — — US claimed
US-20020106413-A1 Mixtures of phenolic and inorganic materials with antimicrobial activity CIBA CORPORATION 2002-08-08 — — US claimed
EP-1190622-A1 Mixtures of phenolic and inorganic materials with antimicrobial activity Ciba SC Holding AG (CH) 2002-03-27 — — EP claimed
US-5185371-A Mixing with isotonic solution from group of ethanol, hydrochloric acid, formaldehyde, povidone with water UNIVERSITY OF SOUTHERN CALIFORNIA (US) 1993-02-09 — — US claimed
US-20250066884-A1 DEGRADABLE AND/OR DEFORMABLE DIVERTERS AND SEALS TERVES LLC (US) 2025-02-27 — — US disclosed
US-12227641-B2 Soil biodegradable blown film bag formulation GREEN IP, LLC (US) 2025-02-18 — — US disclosed
US-12146207-B2 Degradable and/or deformable diverters and seals TERVES, LLC (US) 2024-11-19 — — US disclosed
US-11905787-B2 Degradable deformable diverters and seals TERVES LLC (US) 2024-02-20 — — US disclosed
EP-0055198-B1 PROCESS FOR THE SYNTHESIS OF METACHLOROPHENOLS RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1984-04-04 — — EP disclosed
EP-0055197-A1 Process for the synthesis of metachlorophenols RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1982-06-30 — — EP disclosed
EP-0055196-A1 Process for the synthesis of metachlorophenols RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1982-06-30 — — EP disclosed
EP-0055198-A1 Process for the synthesis of metachlorophenols RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1982-06-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050131100-A1 Mixtures of phenolic and inorganic materials with antimicrobial activity CUTA, PUF60, TYR HSP90AA1 164/4885MEN1 3725/4885CYP3A4 1702/4885
US-20020106413-A1 Mixtures of phenolic and inorganic materials with antimicrobial activity CUTA, PUF60, TYR HSP90AA1 164/4885MEN1 3725/4885CYP3A4 1702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback